In recent years, our understanding of how the immune system interacts with the developing fetus and placenta has greatly expanded. There are many laboratories that provide tests for diagnosis of pregnancy outcome in women who have recurrent pregnancy loss (RPL) or pre-eclampsia. These tests are based on the premise that immune response to the fetus is equivalent to the adaptive immune response to a transplant. New understanding leads to the concept that the activated innate response is vital for pregnancy and this can result in more effective testing and treatment to prevent an abnormal pregnancy in the future. We describe here only three such areas for future testing: one area involves sperm and semen and factors necessary for successful fertilization; another area would determine conditions for production of growth factors necessary for implantation in the uterus; finally, the last area would be to determine conditions necessary for the vascularization of the placenta and growing fetus by activated natural killer (NK) cells (combinations of killer cell immunoglobulin-like receptor (KIR) family genes with HLA-C haplotypes) that lead to capability of secreting angiogenic growth factors. These areas are novel but understanding their role in pregnancy can lead to insight into how to maintain and treat pregnancies with complicating factors. Keywords: male factor; preterm labor; recurrent pregnancy loss; seminal plasma; sperm
INTRODUCTION
When utilizing clinical immunological testing in recurrent pregnancy loss (RPL) or preterm delivery, it should be considered that the primary function of the immune system in pregnancy is angiogenesis and its secondary function is to function as a system to kill and remove foreign pathogens. Alterations in the immune system can affect angiogenesis or the blood flow, which is necessary to maintain placental growth and thereby may divert the immune system from its non-pregnant primary function. At present, the most commonly performed tests to monitor and treat women with RPL are tests for autoantibodies such as antiphospholipid antibodies, antinuclear antibodies and anti-thyroid antibodies. [1] [2] [3] In addition, assays for lymphocyte subsets and their functions, determination of HLA histocompatibility genes and genes related to thrombophilic conditions are used by some physicians to aid in treatment. Some physicians test women to determine if their RPL are due to an inappropriate inflammatory immune response, which may be treated by anti-inflammatory drug regimens. Some of the tests that are performed have been a matter of controversy but one might consider that women with histories of RPL should be tested to determine if a reason for the repeated miscarriages can be identified. Finally, women with preterm delivery usually are tested for infections or fetal fibronectin which can be helpful in the treatment. 4 The immune system is an endocrine-like system capable of producing numerous peptide hormones (cytokines and chemokines). These hormones are key in the vascularization necessary for placental growth and development. 5, 6 They are also vital in sperm development 7 and implantation. 8, 9 A balance of the correct cytokines and chemokines is necessary to acquire the appropriate mix of cells critical for fetal nutrition. Defects or changes in the immune system alter its ability to aid in the vascularization and may cause deleterious effect to the fetus.
WHAT IS IN A NAME?
Immune cells have often been called by names that misrepresent their functions. The primary immune cells in the uterus are NK cells and macrophages, two dubiously named cell types in pregnancy designated by the first activities observed by early investigators of these cells and not necessarily for their primary function. NK cells in the decidua are clearly not killers but are activated and necessary in angiogenesis in the placenta. 10, 11 They are key in spiral artery formation in the mouse and humans have a similar NK that is important activity in placental vascularization and provides for the necessary blood flow at the maternal-fetal interface. 12, 13 In peripheral blood the cells themselves are recognized by the presence of CD56 and CD16. However, CD16 is an IgG receptor and often is absent on NK cells associated with reproductive tissues. CD56 was identified as a nerve cell adhesion receptor and has never been found to be involved in the natural killing for which the cells are named nor for their activity, which is important in reproduction. 14 The activity of NK cells themselves are controlled in part by genes of the killer cell immunoglobulin-like receptor (KIR) family. This family of inhibitory and activating receptors appears to be important in placental growth and development. In these cells activation often appears to be beneficial for fetal and placental growth. The relationship between KIR and HLA-C will be discussed later but most clearly activation of natural killer (NK) cells is important, necessary, and essential for a successful pregnancy. It is the improper activation of NK cells that can be critical and results in poor outcome of the pregnancy. 15 Macrophages have recently been shown to be composed of at least two groups. M1 macrophages are more active as phagocytes and in killing and M2 macrophages in growth and development. Both M1 and M2 types are present in the placenta. 16 M2 type is dominant in tumors and is important in some tumor growth. 17 Clearly the critical cell types important in pregnancy are not those originally conceived and identified by Billington and colleagues. 18, 19 They are not killers nor big eaters but endocrine cells necessary for angiogenesis and cytokine/chemokine secretion necessary for placental/fetal development. In this way, the placenta resembles a tumor much more than a transplant. With this in mind, the clinical importance of immune diagnosis and treatment of recurrent miscarriage needs to be examined.
PREGNANCY ENDOCRINE-LIKE PEPTIDES
Analysis of cytokines found in pregnancy was first investigated by Wegman and colleagues. 20, 21 Athanassakis et al. 22 has been showed that granulocyte-macrophage colony stimulating factor (GM-CSF) was also important in pregnancy. This has been followed by the work of Robertson and her colleagues 23 who have shown GM-CSF is not only important in the female, but its production in sperm can also be necessary. Various other studies have been well documented that cytokines and chemokines play a vital role in human pregnancy. 24 Clearly investigations into the possible uses of a cytokine in the prevention of preterm delivery, and recurrent miscarriage of pregnancy will help with pregnancy outcome.
SEMINAL FLUID AND IMMUNE RESPONSE FOR EMBRYO IMPLANTATION
Seminal fluid contains various cytokines and chemokines or antigens which induce immune changes in female reproductive tract for successful implantation. 25 Seminal fluid also regulates the infiltration of regulatory T cell in the uterus, which provides the maternal immune adaptation necessary for embryo implantation. For improved understanding of how seminal fluid influences the uterus and ultimately assists in successful pregnancy outcome, new therapies for immune-mediated pathologies of pregnancy must be developed. We focused on one of the crucial enzyme which, in part, regulates innate response is Vacuolar ATPase (V-ATPase). 26 V-ATPase is a multisubunit enzyme which is responsible for regulating the acidic environment of intracellular organelles and the extracellular environment via ATP hydrolysis. Its expression in round spermatids was first demonstrated by Wada and colleagues. 27 V-ATPase generally is present in the membrane of intracellular vesicles (lysosomes, endosomes) and is important in cellular processes such as membrane fusion, endocytosis and intracellular transport. V-ATPase is also expressed in the plasma membrane of specialized cells, such as macrophages, renal intercalated cells, osteoclasts and some tumor cells, and regulates the pH of the extracellular environment. 28 V-ATPase also has a role in mammalian reproduction. 29 Our research focuses on the a2 isoform of V-ATPase (a2V-ATPase), which can be detected in the testis, 7 spleen 30 and placenta. 16 The a2 subunit functions to transport H 1 into the intracellular lumen and also functions as an endosomal pH-sensor. 31 There are several lines of evidence showing that a2V-ATPase is involved in various aspects of mammalian reproduction such as spermatogenesis, 7 sperm capacitation, embryonic development, implantation 32 and placentation. 16 The a2 isoform of VATPase is located specifically in the acrosomal membrane upon capacitation of murine sperm. 32 This might regulate an acidic intra-acrosomal pH, which is necessary for processing protease zymogen, essential for fertilization. 33 In agreement with this previous study, a2V-ATPase was highly expressed in the acrosomal region of the capacitated murine sperm but not detected in non-capacitated sperm from the caudal epididymis. 32 This study provided a new insight into a possible association between a2V-ATPase and fertilizing ability of capacitated human sperm, since capacitation is required for fertilization and embryogenesis. 32, 34 Although seminal fluid has been conventionally viewed as transport media for spermatozoa traversing the female reproductive tissues, it is now known to have broader biological actions in regulating female fertility. 35, 36 Seminal fluid contains a complex array of cytokines, chemokines and other bioactive molecules. Seminal fluid induces pro-inflammatory cytokines and chemokines such as GM-CSF, IL-6, IL-8, MCP-1, MIP-3a, and IL-1a in the female reproductive tract. 32, [35] [36] [37] Our recent study showed that exposure of sperm to seminal plasma is essential for the infiltration of macrophages in the preimplantation uterus. 32 In addition, capacitation appears to cause the release of a2NTD, which is the N-terminal portion from a2V-ATPase. We have also shown that a2NTD induces maternal inflammatory cytokines such as leukemia inhibitory factor, IL-1b, TNF-a, MIP-1a, and exposure of the uterus to sperm accompanied by seminal fluid enhances pregnancy success rate. Therefore, a2V-ATPase derived from capacitated sperm may play a key role in expression of cytokines and chemokines in the uterus and control early inflammatory process, which is necessary for implantation. 32 Infiltration of macrophage in the preimplantation uterus is essential for regulation of inflammatory milieu required for successful implantation. 32, 38 Our recent studies have shown that a2V-ATPase expression in spermatozoa obtained from normal fertile men is higher than sperm obtained from infertile men. Similarly, motile spermatozoa had significantly higher a2V-ATPase expression levels than immotile spermatozoa. 34 In accordance with these findings, seminal fluid a2NTD levels were significantly higher in fertile men in comparison to infertile donors. 34 Furthermore, our initial Luminex assays investigating cytokine and chemokine levels in seminal fluids of fertile and infertile men indicate that G-CSF, GM-CSF, MCP-1 and MIP-1 levels are significantly higher in fertile donors. 34 In approximately 30% of couples, male factor infertility is the only cause of infertility, and in another 20%-30% of couples, it is a contributing factor for their infertility. 39 Semen analysis is the most commonly used diagnostic tool for male infertility. Recently, the World Health Organization has issued standards for abnormal semen analysis. 40 However, these standards are not quantitative and do not identify abnormal parameters related to the underlying causes of infertility. To issue these standards, semen obtained only from fertile men were used, and there were no 'threshold values' for sperm concentration, motility and morphology to differentiate men as subfertile, of indeterminate fertility or fertile. 41 Thus, none of these parameters can predict the fertile capacity of sperm or pregnancy outcome with a great deal of confidence. Unfortunately, most clinical laboratories still rely on semen analysis only based on standards to determine plan of care. Indeed, even with techniques such as or in vitro fertilization with intracytoplasmic sperm injection, pregnancy success rates still remain at 25%-30%. This could be partly related to lack of our understanding of the molecular pathology of sperm and semen. 42 Therefore, if a new biomarker could be associated with sperm from infertile men, this would provide a better method to predict fertilization capacity of sperm and pregnancy outcome. These studies are important in terms of evaluating male fertility and predicting the outcome of artificial insemination procedures. If differences can be found between the two groups, then these studies will lead to development of improved methods for semen analysis and possible interventions to improve male fertility.
KIR AND HLA-C REGULATES THE IMMUNE RESPONSIVENESS OF NK CELLS DURING PREGNANCY
During human pregnancy the uterine mucosal lining (decidua) is highly populated with NK cells playing important role in regulation of processes supporting successful placentation. These decidual NK (dNK) cells are characterized by high capacity to produce wide range of growth factors, cytokines and chemokines, which are beneficial for trophoblast migration and trophoblast-mediated remodeling of uterine vessels supplying blood into intervillous space. [43] [44] [45] [46] Oligonucleotide microarray-based analysis revealed that the dNK cells are remarkably distinct when compared to different peripheral blood NK cell subsets. 47 Among the most significantly upregulated genes in dNK cells were the genes coding a KIR which compose a family of activating and inhibitory cell surface receptors. KIRs are highly polymorphic and the numbers of genes that are present in the KIR locus vary substantially across individuals and populations. Generally, KIR haplotypes can be classified into two types: haplotypes AA or Bx. The AA KIR haplotype lacks most of the genes coding activating receptors except for KIR2DS4, while the Bx KIR haplotypes are recognized as having a more diverse repertoire including more than one activating KIR. 48, 49 Among the key ligands for KIR are HLA class I molecules including non-classical HLA-G and classical HLA-C with the C1 or C2 epitope. Extravillous trophoblast has a unique pattern of HLA class I molecules. It expresses both HLA-G and HLA-C, but not the other common molecules for somatic cell HLA-A and HLA-B. 50 The recognition of HLA ligands on trophoblast by KIR will determine the activity of dNK cells, which is imperative to support the vascularization process in the placenta.
Several genetic population studies analyzed the relationship between maternal KIR profile and susceptibility to various pregnancy related disorders including RPL, [51] [52] [53] [54] [55] pre-eclampsia, 56, 57 and fetal growth restriction. 51 It was found that the combination of maternal AA KIR haplotype and fetal HLA-C2 is associated with a higher risk of pre-eclampsia. 58 Interestingly the worldwide analysis of distribution of HLA-C2 alleles and KIR AA revealed inverse correlation, which is thought to be due to selective pressure for optimum reproductive performance. 58, 59 The dNK cells upon an interaction with trophoblast would receive a stronger inhibitory signal if the trophoblast expresses HLA-C2 than HLA-C1 due to higher complementary binding of HLA-C2 with its ligand. 60 Because the KIR AA haplotype lacks most of activating KIR, it is thought that women with AA KIR/ fetal HLA-C2 combination have insufficient dNK cell activation to support spiral artery remodeling which is affected in pre-eclampsia.
Hiby and co-authors 51 also found an increased frequency of KIR AA haplotype in a cohort of women with RPL, although in several other studies, this association was not observed. [52] [53] [54] [55] Various etiologies are implicated in RPL and a substantial number of cases are unexplained or thought to be due to autoimmune abnormalities. It is possible that different KIR/ HLA-C combinations including the effect of maternal HLA-C background play causative role in RPL. Recently, it was shown that KIR2DS1 plays an important role during pregnancy, as dNK cell activation via KIR2DS1 triggers secretion of soluble factors including GM-CSF which was demonstrated to be beneficial for placentation 61 and could contribute to higher birth weight. 56 Indeed, the extent of the maternal NK cell response is determined by both the availability of corresponding KIR ligands on trophoblast as well as by the maternal HLA-C background, which is thought to be responsible for shaping the maternal NK cell repertoire. 62 It is known that KIR2DS1/HLA-C2 receptor/ligand interaction contributes to functional NK cell education; KIR2DS1pos NK cells from C2 negative individual demonstrated strong alloreactive activity against HLA-C2 targets, in contrast to low or absent alloreactivity if the NK cells were from a C2-positive individual. 63, 64 Additional studies would be helpful to evaluate whether there is a genetic susceptibility to RPL in KIR2DS1/HLA-C2 co-expression cases.
PRETERM BIRTH
Preterm birth is considered to be the most common reason of neonatal morbidity and mortality not due to congenital anomalies in the developed world. 65 Approximately 40% cases of preterm births occur due to microbial invasion in the gestational compartment. 66 Gram-negative bacterial infection is well established cause of preterm labor in various animal models. 67 Wang and Hirsch 68 have been reported that activation of signaling throughTLR4 ligand is major cause of preterm labor during Gram-negative bacterial infection. Other groups also reported the similar finding. 69, 70 Another major infectious process during preterm labor is simultaneous infection of virus and bacteria in pregnant women. This form of preterm labor is well demonstrated in mouse model of infection-induced preterm delivery. 71 We and others have demonstrated that the combined activation of Toll-like receptor 2 (TLR2) and TLR3 using peptidoglycan (PGN) and polyinosinic : cytidylic acid (poly(I : C)) yields a dramatic synergy in the labor response and expression of inflammatory mediators in gestational tissues. 26, [71] [72] [73] [74] Such combined stimulation might occur in nature in at least four scenarios: (i) engagement of TLR4; (ii) activation of both TLR3 and another TLR simultaneously by a single organism (e.g., murine cytomegalovirus, herpes simplex virus and Schistosoma mansoni; 75, 76 (iii) superinfection, in which a host is infected simultaneously by more than one microorganism, such as a virus and a bacterium; 77 and (iv) activation of TLRs by one of several known, endogenously produced TLR ligands together with an exogenous pathogen. 78, 79 PRETERM LABOR AND PYROPTOSIS Caspase-1 plays a central role in various inflammatory diseases as a protease that activates the pro-inflammatory cytokines proIL-1beta and proIL-18. Recently, pyroptosis, a caspase-1-dependent type of programmed cell death, has been identified that is able to support secreted IL-1 and IL-18 in triggering an inflammatory response. 80 We have recently shown that a 'double hit' of PGN1poly(I : C) induces expression of NLRP3 (NACHT, LRR and PYD domains-containing protein 3)and activation of caspase-1 which could induce pyroptosis and simultaneously the activation of apoptosis and inflammatory processes, which leads to preterm labor (Figure 1) . 26 It might possible that this simultaneous activation of apoptosis and inflammatory is linked with reduction of a2 isoform of VATPase. We have also demonstrated that reproductive tissue had increased apoptotic death via extrinsic pathway of apoptosis (Figure 1) . 26 Others have shown increased apoptotic cell death at the fetomaternal interphase during preterm labor. levels of the a2 isoform of vacuolar ATPase can result in preterm labor and could be biomarkers.
PRETERM LABOR AND MACROPHAGE PHENOTYPES
Macrophages are an important innate immune cell infiltrate in the uterus during successful implantation 32, 38 and placentation. 16 These macrophages provide a pivotal role in shaping the cytokine profile at the maternal-fetal interface. 82 We have shown that both M1 inflammatory and M2 anti-inflammatory macrophage phenotypes are increased in the uterus prior to implantation and required for successful placentation. 16 During preterm labor, it has been previously reported that macrophage infiltration is increased in the uterus. 83 Depletion of macrophages prevented cervical remodeling and preterm delivery in lipopolysaccharide-treated mice. 84 Our study of macrophage phenotypes showed that during preterm labor induced by double hit of PGN1poly(I : C), increased the number of macrophages (F4/ 801) that were double-positive for CD11c and CD206. 26 Wentworth et al. 85 has demonstrated these double positive CD11c
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1 are highly inflammatory and increased in the adipose tissues that impair insulin action on adipocytes. In summary, during preterm labor apoptosis and inflammatory processes are simultaneously activated. Molecules that are the linking bridge between apoptotic and inflammatory processes might be useful therapeutic targets for preterm labor.
SUMMARY
In the future, clinical laboratory tests which measure immune parameters that are related to non-traditional aspects of the immune response may be valuable to predict successful or uncomplicated pregnancy outcomes or the necessity for further treatment. These tests may involve detection of genes, functional assays or quantitation of secreted factors. Both NK cells and macrophages are present in the placenta and play an important role in successful pregnancy. The dNK cells in the placenta must be activated to support spiral artery remodeling. The appropriate combination of KIR activating receptors which interact with ligands encoded by the HLA-C1 haplotype genes can lead to the secretion of soluble factors including GM-CSF which are beneficial for placentation; in contrast, if the trophoblast expresses HLA-C2 ligands which interact with inhibitory receptors on dNK, these cells are not activated and the result can be pre-eclampsia, fetal growth restrict and RPL. By testing for the presence of KIR haplotype genes (for activating and inhibitory KIR receptors) as well as HLA-C haplotype genes, the potential expression of KIR receptors and their ligands can be determined. The appropriate combination will lead to activation of dNK cells and angiogenesis during placental growth and successful pregnancy. Women with the inappropriate combination may have difficulties during their pregnancy. Another potential new test of the future is the determination of the levels of a2V V-ATPase and a2NTD following capacitation of sperm; this test can give information regarding fertility outcome. Macrophages in the placenta also release cytokines necessary for placentation and determination of their phenotypes and the endocrine-like cytokines and chemokines they secrete can also lead to clues regarding pregnancy outcome. The role of these newly identified aspects of the immune response has led to new understanding of how to maintain pregnancies and can be invaluable in diagnosis and treatment of pregnancy complications.
